NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/21/2024
Back to search
Official data from USPTO
SPECTRALMD DEEPVIEW
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
03/21/2024
Trademark type
Combined
Nice classes
10
Filing date
07/01/2016
Registration date
07/24/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/21/2024
Last transaction
03/21/2024
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/04/2016
First use in commerce
02/04/2016
Drawing code
3
Owner type
03
Owner location
Dallas, TX, US
Examiner
CARLSON, KRISTIN
Law office
L50
Current location
TMEG LAW OFFICE 105
Mark description
The mark consists of a design of three arrows pointing downward and the stylized words "SPECTRALMD" with the words "DEEPVIEW" directly below the letters "LMD" in the word "SPECTRALMD". The letters "MD" and the word "DEEP" are bolded.
Holders and representatives
Holders
Spectral MD, Inc
Representatives
Kay Lyn Schwartz FOLEY & LARDNER LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical imaging apparatus for imaging blood flowtissue perfusionwound healingviable and nonviable tissuewoundburnsoreskinsub-skin conditions; Medical imaging diagnostic apparatus for detecting viable skin; Medical imaging diagnostic apparatus for detecting viable and nonviable tissue and skin; Medical imaging apparatus for detecting sub-skin conditions; Medical imaging apparatus for use to observe and analyze changes in tissue perfusion and blood flow and diagnosing viable and nonviable tissue and skin; Medical imaging apparatus for screening and imaging the skin and tissue for medical purposes
Publications
History of USPTO decisions and trademark events.
34 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/21/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/21/2024
E815
TEAS SECTION 8 & 15 RECEIVED
09/26/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/24/2023
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
09/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/24/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/19/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/18/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/05/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/05/2018
IUAF
USE AMENDMENT FILED
05/16/2018
EISU
TEAS STATEMENT OF USE RECEIVED
05/16/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/07/2018
EX1G
SOU EXTENSION 1 GRANTED
02/05/2018
EXT1
SOU EXTENSION 1 FILED
02/05/2018
EEXT
SOU TEAS EXTENSION RECEIVED
02/05/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/05/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/11/2017
PUBO
PUBLISHED FOR OPPOSITION
07/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/21/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/06/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2017
ACEC
AMENDMENT FROM APPLICANT ENTERED
05/16/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/16/2017
ALIE
ASSIGNED TO LIE
05/12/2017
PAPER RECEIVED
04/20/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/13/2017
CNRT
NON-FINAL ACTION MAILED
10/17/2016
CNRT
NON-FINAL ACTION WRITTEN
10/15/2016
DOCK
ASSIGNED TO EXAMINER
10/12/2016
MAFR
APPLICATION FILING RECEIPT MAILED
07/12/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2016
Continuous trademark protection
Get notified about every new filing that threatens SPECTRALMD DEEPVIEW or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.